Refresh

Claris Lifesciences Ltd. - Research Center

533288 CLARIS Group (B) BSE data
Back to Company

Results

Statement

More

Profit & Loss Account
(Rs crore)
Mar ' 17 Mar ' 16 Mar ' 15 Dec ' 13 Dec ' 12
Income

Operating income

21.12 547.22 722.28 638.18 718.01
Expenses

Material consumed

9.17 487.75 454.31 253.21 248.05

Manufacturing expenses

- - 3.56 18.08 34.72

Personnel expenses

27.74 18.58 66.62 47.25 49.23

Selling expenses

0.78 1.54 - - -

Adminstrative expenses

42.47 31.03 111.44 161.94 154.71

Expenses capitalised

- - - - -

Cost of sales

80.15 538.92 635.93 480.46 486.71

Operating profit

-59.04 8.30 86.35 157.72 231.31

Other recurring income

48.03 40.97 76.26 40.50 12.13

Adjusted PBDIT

-11.01 49.27 162.61 198.21 243.44

Financial expenses

3.73 3.87 31.04 52.10 64.91

Depreciation

3.32 6.11 29.58 57.96 71.79

Other write offs

- - - - -

Adjusted PBT

-18.07 39.29 101.99 88.15 106.73

Tax charges

-12.98 7.86 -31.47 21.99 31.86

Adjusted PAT

-5.09 31.42 133.46 66.16 74.87

Non recurring items

16.65 -37.83 5.23 15.06 -0.45

Other non cash adjustments

- - - - -

Reported net profit

11.56 -6.41 138.69 81.22 74.42

Earnigs before appropriation

508.76 606.76 613.17 550.07 489.34

Equity dividend

8.69 8.69 - 47.67 10.69

Preference dividend

- - - - -

Dividend tax

2.22 2.22 - 9.76 2.07

Retained earnings

497.85 595.85 613.17 492.64 476.58
Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist
© 2024 Rediff.com